Attention!

What is the drug TYREUS®

TYREUS® contains the active ingredient nitizinone. TYREUS® is used to treat a rare disease called hereditary tyrosinemia type 1 in adults, adolescents and children (at any age).

With this disease, the body is unable to completely break down the amino acid tyrosine (amino acids are the building blocks of our proteins), forming harmful substances. These substances accumulate in the body. Nitisinone blocks the breakdown of tyrosine and no harmful substances are formed.

For the treatment of hereditary tyrosinemia type 1, the patient must follow a special diet while taking this medication, because tyrosine will remain in the body. This special diet is based on a low content of tyrosine and phenylalanine (another amino acid).

Packaging

60 capsules each in a plastic bottle, sealed with a polypropylene cap with a desiccant, child protection and first opening control.

The bottle together with the leaflet insert is placed in a pack of cardboard.

Indications for use

Hereditary tyrosinemia type 1.

Efficacy and safety studies

In accordance with current legislation, the drug has proven its effectiveness, safety and quality during state registration. For registration purposes, a bioequivalence study was conducted with the original (reference) medicinal product.